MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer

Journal of Cellular Biochemistry

Volumn 62, Issue SUPPL. 24, 1996, Pages 210-217

  Johnson, Bruce E ^a,b   Russell, Edward ^a   Simmons, Alfreda M ^a   Phelps, Ruby ^a   Steinberg, Seth M ^a   Ihde, Daniel C ^a   Gazdar, Adi F ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL NAVAL MEDICAL CENTER   (United States)

^c NONE

Author keywords

drug therapy; lung neoplasms; mortality; oncogenes; pathology

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; DNA DETERMINATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; CELL CULTURE; FEMALE; GENETICS; LIFE TABLE; LUNG TUMOR; MALE; MORTALITY; ONCOGENE MYC; PATHOLOGY; SMALL CELL CARCINOMA; SURVIVAL;

DNA;

CARCINOMA, SMALL CELL; DNA, NEOPLASM; FEMALE; GENE AMPLIFICATION; GENES, MYC; HUMANS; LIFE TABLES; LUNG NEOPLASMS; MALE; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 0029681702     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.240630516     Document Type: Article

References (30)

1. Yokota J, Wada M, Yoshida T, Noguchi M, Terasaki T, Shimosato Y, Sugimura T, Terada M (1988): Heterogeeity of lung cancer cells with respect to the amplification and rearrangement of myc family oncogenes. Oncogene 2:607-611.
2. Little CD, Nau MM, Carney DN, Gazdar AF, Minna JD (1983): Amplification and expression of the c-myc oncogene in human lung cancer cell lines. Nature 306:194-196.
3. Morstyn G, Brown J, Novak U, Gardner J, Bishop J, Garson M (1987): Heterogeneous cytogenetic abnormalities in small cell lung cancer cell lines. Cancer Res 47:3322-3327.
4. Kiefer PE, Bepler G, Kubasch M, Havemann K (1987): Amplification and expression of protooncogenes in human small cell lung cancer cell lines. Cancer Res 47: 6236-6242.
5. Waters JJ, Ibson JM, Twentyman PR, Bleehan NM, Rabbitts PH (1988): Cytogenetic abnormalities in human small cell lung carcinoma: Cell lines characterized for myc gene amplification. Cancer Genet Cytogenet 30:213-223.
6. Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T, Takahashi T (1989): Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res 49:2683-2688.
7. Brennan J, O'Connor T, Makuch RW, Simmons AM, Russell E, Linnoila RI, Phelps RM, Gazdar AF, Ihde DC, Johnson BE (1991): myc family DNA amplification in 107 tumor and tumor cell lines from patients with small cell lung cancer treated with different combination chemotherapy regimens. Cancer Res 51:1708-1712.
8. Kok K, Osinga J, Schotanus DC, Berendsen HH, De Leij LFMH, Buys CHCM (1989): Amplification and expression of different myc-family genes in a tumor specimen and 3 cell lines derived from one small-cell lung cancer patient during longitudinal follow-up. Int J Cancer 44:75-78.
9. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB, Vogelstein B (1986): Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233:461-464.
10. Johnson BE, Makuch RW, Simmons AD, Gazdar AF, Burch D, Cashell AW (1988): myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res 48:5163-5166.
11. Gemma A, Nakajima T, Shiraishi M, Noguchi M, Gotoh M, Sekiya T, Niitani A, Shimosato Y (1988): myc family gene abnormality in lung cancers and its relation to xenotranplantability. Cancer Res 48:6025-6028.
12. Shiraishi M, Noguchi M, Shimosato Y, Sekiya T (1989): Amplification of protooncogenes in surgical specimens of human lung carcinomas. Cancer Res 49:6474-6479.
13. Noguchi M, Hirohashi S, Hara F, Kojima A, Shimosato Y, Shinkai T, Tsuchiya R (1990): Heterogenous amplification of myc family oncogenes in small cell lung carcinoma. Cancer 66:2053-2058.
14. Johnson BE, Ihde DC, Makuch RW, Gazdar AF, Carney DN, Oie H, Russell E, Nau MM, Minna JD (1987): myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. J Clin Invest 79:1629-1634.
15. Nau MM, Brooks BJ, Battey J, Sausville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD (1985): L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer. Nature 318:69-73.
16. Gazzeri S, Brambilla E, Jacrot M, Chauvin C, Benabid AL, Brambilla C (1991): Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res 51:2566-2571.
17. Nau MM, Brooks BJ Jr, Carney DN, Gazdar AF, Battey JF, Sausville EA, Minna JD (1986): Human small-cell lung cancers show amplification and expression of the N-myc gene. Proc Natl Acad Sci USA 83:1092-1096.
18. Sekido Y, Takahashi T, Makela TP, Obata Y, Ueda R, Hida T, Hibi K, Shimokata K, Alitalo K (1992): Complex intrachromosomal rearrangement in the process of amplification of the L-myc gene in small-cell lung cancer. Mol Cell Biol 12:1747-1754.
19. Gazdar AF, Carney DN, Nau MM, Minna JD (1985): Characterization of variant subclasses of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2924-2930.
20. Johnson BE, Battey JF, Linnoila I, Becker KL, Makuch RW, Snider RH, Carney DN, Minna JD (1986): Changes in the phenotype of human small cell lung cancer cell lines after transfection and expression of the c-myc. J Clin Invest 78:525-532.
21. Johnson BE, Brennan JF, Ihde DC, Gazdar AF (1992): MYC family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. J Natl Cancer Inst Monogr 13:39-43.
22. Bunn PA, Lichter AS, Makuch RW, Cohen MH, Veach SR, Matthews MJ, Johnston-Anderson A, Edison M, Glatstein E, Minna JD, Ihde DC (1987): Chemotherapy alone or chemotherapy with chest irradiation therapy in limited stage small cell lung cancer. Ann Intern Med 106:655-662.
23. Ihde DC, Mulshine JL, Kramer BS, Steinberg SM, Linnoila RI, Gazdar AF, Edison M, Phelps RM, Lesar M, Phares JC, Grayson J, Minna JD, Johnson BE (1994): Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer. J Clin Oncol 10:2022-2034.
24. Johnson BE, Salem C, Nesbitt J, Gazdar AF, Lesar M, Phelps R, Edison M, Linnoila RI, Phares J, Pass H, Mulshine JL, Minna JD, Glatstein E, Ihde DC (1993): Limited stage small cell lung cancer treated with concurrent hyperfractionated chest radiotherapy and etoposide/cisplatin. Lung Cancer 9:321-326.
25. Carney DN, Gazdar AF, Bepler G, Guccion JG, Marangos PJ, Moody TW, Zweig MH, Minna JD (1985): Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913-2923.
26. Gazdar AF, Steinberg SM, Russell EK, Linnoila RI, Oie HK, Ghosh BC, Cotelingam JD, Johnson BE, Minna JD, Ihde DC (1990): Correlation of in vitro drug-sensitivity testing with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial. J Natl Cancer Inst 82:117-124.
27. Mantel N (1963): Chi-square tests with one degree of freedom: Extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 58:690-700.
28. Kaplan E, Meier P (1958): Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481.
29. Mantel N (1966): Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170.
30. Johnson BE, Whang-Peng J, Naylor SL, Zbar B, Brauch H, Lee E, Simmons A, Russell E, Nam MH, Gazdar AF (1989): Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. J Natl Cancer Inst 81:1223-1228.